Ro60-0175

Ro60-0175
Clinical data
Other names(S)-5,6-Difluoroindolmethylethylamine
Identifiers
  • (S)-6-Chloro-5-fluoro-1H-indole-2-propanamine
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
CompTox Dashboard (EPA)
ECHA InfoCard100.189.524
Chemical and physical data
FormulaC11H12ClFN2
Molar mass226.68 g·mol−1
3D model (JSmol)
  • C[C@@H](Cn1ccc2c1cc(c(c2)F)Cl)N
  • InChI=1S/C11H12ClFN2/c1-7(14)6-15-3-2-8-4-10(13)9(12)5-11(8)15/h2-5,7H,6,14H2,1H3/t7-/m0/s1
  • Key:XJJZQXUGLLXTHO-ZETCQYMHSA-N
  (verify)

Ro60-0175, also known as (S)-5,6-difluoroindolmethylethylamine, is a serotonin receptor agonist of the isotryptamine group developed by Hoffmann–La Roche, which has applications in scientific research.

It acts as a potent and selective agonist of both the serotonin 5-HT2B and 5-HT2C receptor subtypes, with good selectivity over the closely related serotonin 5-HT2A subtype, and little or no affinity at other receptors. However, Ro60-0175 also activates the serotonin 5-HT2A receptor less potently than the serotonin 5-HT2B and 5-HT2C receptors.

In combination with the selective serotonin 5-HT2C receptor antagonist SB-242084, Ro60-0175 robustly induces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. This effect is abolished by addition of the selective serotonin 5-HT2A receptor antagonist ketanserin or volinanserin. The preceding findings suggest that Ro60-0175 may be a serotonergic psychedelic and may have hallucinogenic effects in humans at sufficiently high doses.